Loading...
PDCT-17 (LTBK-11). PNOC007: H3.3K27M SPECIFIC PEPTIDE VACCINE COMBINED WITH POLY-ICLC FOR THE TREATMENT OF NEWLY DIAGNOSED HLA-A2(+) H3.3K27M MIDLINE GLIOMAS
OBJECTIVE: To assess within a multi-center trial the safety of H3.3K27M specific peptide vaccine in combination with poly-ICLC in HLA-A02.01(+) patients diagnosed with H3.3K27M(+) diffuse midline gliomas. METHODS: Subjects 3–21 years of age with CLIA confirmed H3.3K27 mutation status were eligible....
Na minha lista:
| Udgivet i: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Oxford University Press
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6873621/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz219.1200 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|